PI3Kα-IN-12 is a highly selective PI3Kα inhibitor (IC50: 1.2 nM) with antitumor activity; it inhibits HCT-116 and U87-MG cell proliferation (IC50 values of 0.83 and 1.25 μM, respectively) and induces tumor regression in a U87-MG xenograft mouse model when administered intraperitoneally at 40 mg/kg.